Jin Rong Jie·2025-08-19 11:52Group 1 - The core viewpoint of the article highlights that Spring Medical's stock closed at 22.93 yuan, down 2.76%, with a rolling PE ratio of 68.79 times and a total market value of 8.795 billion yuan [1] - The average PE ratio for the medical device industry is 59.49 times, with a median of 40.19 times, placing Spring Medical at the 91st position in the industry ranking [1] - As of March 31, 2025, Spring Medical has 7,167 shareholders, an increase of 501 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including spinal, trauma, joint, sports medicine, bone repair materials, surgical instruments, PRP preparation kits, and negative pressure wound drainage kits [1] - The company was recognized as a champion enterprise in the artificial joint prosthesis manufacturing industry by the Ministry of Industry and Information Technology in 2024 [1] - In the latest quarterly report for Q1 2025, Spring Medical achieved an operating income of 230 million yuan, a year-on-year increase of 3.60%, and a net profit of 58.071 million yuan, a year-on-year increase of 5.20%, with a gross profit margin of 66.69% [1]